Eugene Kalmuk
Internal Medicine · Cheektowaga, NYNPI 1114912367
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.6% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,789 and has fallen 99.0% since, to $18 in 2023.
Across 173 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$444
- AstraZeneca$437
- Novo Nordisk$342
- Astellas Pharma US Inc$223
- Pfizer$187
- Amarin Pharma, Inc.$158
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,62493%
- Education$2117%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 21 | $444 |
| AstraZeneca | 27 | $437 |
| Novo Nordisk | 36 | $342 |
| Astellas Pharma US Inc | 8 | $223 |
| Pfizer | 9 | $187 |
| Amarin Pharma, Inc. | 9 | $158 |
| AbbVie(2 entities) | 9 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $127 |
| Johnson & Johnson | 7 | $105 |
| Amgen(2 entities) | 6 | $98 |
| Lilly USA, LLC | 6 | $97 |
| Boehringer Ingelheim | 5 | $94 |
| Kowa Pharmaceuticals America, Inc. | 5 | $82 |
| Daiichi Sankyo Inc. | 4 | $66 |
| Merck | 4 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Novartis | 2 | $27 |
| Alfasigma USA, Inc. | 2 | $26 |
| Abbott | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$228
- ELIQUIS$110
How this compares
$2,835 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Cheektowaga
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.